Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

Change Font Size

Audit (A-01-07-00003)

Review of Medicaid Outpatient Drug Expenditures in Connecticut for the Period October 1, 2003, Through September 30, 2005

Executive Summary

For fiscal years 2004 and 2005, Connecticut claimed $122,000 ($62,000 Federal share) in Medicaid reimbursement for drugs that were no longer eligible for reimbursement. The State agency also claimed $18.5 million ($9.4 million Federal share) for drug products that were not listed on the Centers for Medicare and Medicaid Services quarterly drug tapes and thus may not have been allowable for Medicaid reimbursement.

Complete Report

Download the complete report (PDF)

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201